Blood Plasma Freezers Market

Market overview: 

Market Overview

The market for blood plasma freezers is propelled by numerous factors, shaped by distinct elements that play a role in its development trajectory. A substantial catalyst for this market is the growing demand for blood plasma utilized in diverse medical procedures such as transfusions, therapies, and treatments. Concurrently, continuous advancements in medical technology are expanding the range of applications for blood plasma, thereby elevating the necessity for sufficient storage solutions. 

In addition, the rising incidences of chronic diseases, most of which require plasma therapies, drive demand in the market. On the other hand, strict regulations on the storage and transportation of blood plasma stress the use of specific freezers, thereby boosting the market. The technological advancement evident in freezer design, including advanced systems to monitor and control temperatures, helps support the growth of the market with regard to enhancing efficiency and safety aspects in plasma storage.

Moreover, regulatory compliance and quality standards bring in a new level of difficulty that entails constant monitoring and checking of freezer performance. Also, with changing technology and the introduction of alternative storage methods, there is always the risk that they may present a challenge to the traditional blood plasma freezer market. Therefore, innovation and flexibility are also continuously needed to remain in the competition. Addressing these challenges involves collaboration between manufacturers, medical professionals, and regulatory bodies to ensure the safe and efficient conservation of this critical medical product.

In 2023 Blood Plasma Freezers Market was valued at USD 539 million and it is projected to grow to USD 775 million by 2032 with CAGR of 5%

Blood Plasma Freezers Market

Size, by Product, - (USD Billion)

Upright Freezers

Chest Freezers

Undercounter Freezers

Other Products

The Market will Grow

At the CAGR of:

5%

The Forecast Market

Size for in USD:

$775 million

Growth Factors

1. Expanding Applications:

Plasma in medical therapies is expanding sharply beyond its traditional uses. Plasma is increasingly becoming vital for the treatment of a host of medical disorders, such as hemophilia, since it provides essential clotting factors, and in immunodeficiency disorders, since it enhances immune response. Plasma also has an important role in organ transplantation; it is used to prevent organ rejection and to prevent bleeding during surgical interventions. In view of the increasing identification and exploitation of new therapeutic applications for plasma, a secure and scalable storage infrastructure becomes more and more necessary. This should be able to monitor quality and efficacy for very long periods while making plasma available to an ever-growing demographic of patients worldwide.

2. Aging Population: 

The world is undergoing tremendous demographical change, with a constantly high percentage of its population sliding into higher age brackets. This trend of population aging goes hand in hand with an increasing burden from chronic diseases, among them cardiovascular conditions, cancer, and autoimmune disorders—most of these conditions requiring plasma or plasma-derived therapies for effective treatment. One such good example would be patients suffering from chronic inflammatory diseases that can be treated with immunoglobulin therapy derived from plasma.

Hence, this segment of the growing elderly population is creating a steep rise in demand for plasma-derived therapies. Healthcare centers should therefore avail storage facilities for blood plasma with effective and trustworthy solutions that store large volumes of plasma to meet the needs of an increasing number of patients to satiate this growing demand.

3. Progress in Plasma Therapy: 

Ongoing research and development in plasma therapy helps to come up with new medical applications associated with plasma. These involve new intervention strategies against rare diseases and the establishment of concepts leading toward the strategies of personalized medicine and ongoing investigation into plasma's unique properties in the emerging therapeutic modalities. One example is convalescent plasma therapy, a treatment modality that has shown some promise against viral infections, also indicative of possible applications of plasma in new medical fields. The demand for storage facilities increases with the continuous creation of new applications and therefore calls for investment in upgrading these facilities with more advanced storage technologies. This progress justifies the continuous investment in plasma storage infrastructure to meet its changeable and progressive nature of plasma-using medical therapies.

Market Trends:

Sustainable Models: The manufacturers are continuously developing energy-efficient blood plasma freezers with advanced insulating materials and cooling mechanisms. These developments help reduce energy consumption and align with the global goals of sustainability, thus helping healthcare institutions reduce their impact on the environment.

Binding of Renewable Energy: A growing trend in the market today with respect to the application of renewable energy sources is the binding of solar power with blood plasma freezer systems since this offers an eco-sustainable operation for the devices, more so within regions that possess high potential for solar energy.

Government Incentives: Many governments are developing incentive programs to encourage the adoption of energy-efficient blood plasma freezers in healthcare facilities. Such programs could include tax incentives, grants, or subsidies, helping in the transformation process towards more sustainable operational practices in the healthcare industry.

TCO Analysis: Healthcare providers are becoming ever more interested in the total cost of ownership as a key factor when considering blood plasma freezers. This detailed analysis looks beyond upfront acquisition costs to factors such as energy usage, maintenance commitments, and future replacement costs, enabling better-informed and more cost-effective purchasing decisions.

Blood Plasma Freezers Market

Size, by Product, - (USD Billion)

The Market will Grow

At the CAGR of:

5%

The Forecast Market

Size for in USD:

$775 million

Key players:

1. Thermo Fisher Scientific (US)
2. Eppendorf AG (Germany)
3. Haier Biomedical (China)
4. PHC Holdings Corporation (Japan)
5. Helmer Scientific (US)
6. Liebherr (Germany)
7. B Medical Systems (US)
8. Blue Star Limited (India)
9. Merck KGaA (Germany)
10. Thermo Forma (US)
11. Thermo Haake (Germany)
12. Sanyo Electric (Japan)
13. Yamato Scientific Company (Japan)
14. So-Low Environmental Equipment Co., Ltd. (US)
15. Arctiko (Denmark)
16. Gram Cabinets (Denmark)
17. SPIR Scientific (US)
18. Froilabo (France)
19. Twinstar Deep Freeze (India)
20. Azbil Corporation (Japan)

Recent Developments

WILMINGTON, N.C.-- The PPD clinical research business of Thermo Fisher Scientific, the world leader in serving science, has been honored for industry leadership in digital services by Information Services Group (ISG), a leading global technology research and advisory firm. The business was recognized as an ISG Provider Lens Leader for its digital transformation services in clinical development and patient engagement, as well as pharmacovigilance and regulatory affairs.

Hamburg/Cambridge, March 27, 2024- The globally active Eppendorf Group announced the 5-year partnership renewal with LabCentral, a renowned life sciences incubator, dedicated to empowering innovative biotech startups. As a Partner since 2014 and Founding Sponsor since 2019, the Eppendorf Group continues its commitment to fostering scientific breakthroughs and supporting the next generation of biotech innovators. 

DAVIDSON, North Carolina, May 15, 2023 — Trane Technologies (NYSE:TT), a global climate innovator, has acquired Helmer Scientific, a leader in precision temperature-controlled storage and processing solutions for hospitals, labs, blood banks, and pharmacies. This acquisition supports Trane Technologies' strategy to bring climate innovation and temperature-control solutions to more industries, including the fast-growing life sciences and clinical health markets.

Market segmentation:

1. By Type:

• Upright Freezers
• Chest Freezers
• Undercounter Freezers

2. By Application:

• Blood Banks & Hospitals
• Plasma Fractionation Facilities
• Research Laboratories

3. By Capacity

• Up to 100 Liters
• 100 to 300 Liters
• 300 to 500 Liters
• Above 500 Liters

4. By End-User

• Blood Banks
• Hospitals
• Pharmaceutical Companies
• Research Laboratories
• Biotechnology Companies
• Others

5. By Technology

• Conventional Refrigeration
• Energy-Efficient Refrigeration
• Advanced Cooling Technology
• Other Technologies

By Region

• North America
• Europe
• Asia-Pacific
• Latin America
• Middle East & Africa

Blood Plasma Freezers Market TO (USD BN)

CAGR OF

5%

Blood Plasma Freezers Market

775 million%

Market Opportunities

Development of Computationally Acceptable Alternatives: 

The cost of current-generation freezers for blood plasma is extremely high. This could make them unaffordable for many regions, especially those with limited resources. The manufacturers can remedy this shortcoming through the development of cheap alternatives, actualized by simplified designs, alternative materials, or multiple layers of product lines with different functionalities. Such advancements would provide better access to more advanced plasma storage solutions and render them cost-effective for a larger network of medical facilities and regions.

Investment in Education and Training: 

The successful storage of blood plasma comes with the requisite expertise cleaner. The manuals and instruction will help healthcare providers to invest much more in tailor-made education and training for healthcare providers, especially in emerging markets. Such programs will ensure that the blood plasma storage systems are appropriately utilized, maintained, and handled to assure effective resource management with high-quality patient outcomes.

Market Restraints:

Technical Competency:

The operation and upkeep of ultra-low temperature freezers necessitate specialized technical expertise. These sophisticated systems are crucial for the preservation of blood plasma at remarkably low temperatures and entail intricate refrigeration technologies, accurate temperature regulation, and careful maintenance protocols.

In remote or underserved areas, accessibility to properly trained personnel may become very challenging. In the absence of necessary experts who have been appropriately trained for installation, operation, and maintenance of such systems—in-country, regionally, or locally—one may have to face longer downtimes, higher malfunction risks, and, possibly, severe plasma storage quality compromising situations. 

Further, the financial burdens and logistical considerations associated with recruiting or training competent technicians could be sizeable in many facilities, particularly those located in financially stressed situations. This can significantly curtail the prospects for the integration of ultra-low temperature freezers in these resource-scarce regions, hence affecting market growth and the broader applicability of sophisticated plasma storage technologies.

Conclusion

This essentially translates to the growth of plasma, technological improvements in plasma freezers, and an aging population that is increasingly reaching out to such products for their storage solutions—these will largely contribute to blood plasma freezers' increased demand. Though this market looks promising and holds huge potential to increase from USD 539 million in 2023 to USD 775 million in 2032, the way forward is expensive and requires highly specialized technical experts to see that all regulatory standards are met. This particularly includes effort toward cost-effective alternatives, investment for training, and using energy-efficient technologies. Therefore, numerous players, from manufacturers and healthcare providers to regulatory bodies, need to come together for overcoming these barriers and ensuring the continuous progress and access of plasma-storage-solution improvements.